57 results
424B5
MIRM
Mirum Pharmaceuticals Inc
2 Nov 23
Prospectus supplement for primary offering
4:59pm
coronavirus, or together with its variants, the COVID-19 pandemic, including political or social movements arising in relation to the COVID-19 pandemic on our
8-K
EX-99.1
lhqeq
13 Oct 23
Other Events
4:16pm
8-K
EX-2.1
45j6 x3nbo07
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-4.1
99ois 9p5exm3ctl4z8
17 Apr 23
Mirum Pharmaceuticals Announces Proposed Convertible Senior Notes Offering
4:17pm
S-3ASR
EX-4.8
wsocdqz1 uf34f
9 Sep 22
Automatic shelf registration
4:31pm
S-3ASR
EX-4.7
m7bgg
9 Sep 22
Automatic shelf registration
4:31pm
S-3ASR
EX-4.6
4paev0tbpcwd 6dj
9 Sep 22
Automatic shelf registration
4:31pm
S-3ASR
yva750m0c279109
9 Sep 22
Automatic shelf registration
4:31pm
424B5
bemr2p8
10 Aug 22
Prospectus supplement for primary offering
5:07pm
8-K
EX-1.1
2xx4vqwml i59ukd5
10 Aug 22
Other Events
12:00am
424B5
0xu9efpeks
9 Aug 22
Prospectus supplement for primary offering
12:00am